Preoperative Risk Stratification for Major Events

Abstract

The preoperative assessment of surgical patients, including colorectal patients, has undergone significant changes over the last 20 years. The rationale for such changes is based on evidence-based guidelines that showed a minimal clinical impact from broad base testing in healthy patients. Additionally, nonselective testing has been shown to be a large economic burden to the American health care system. As such, a tailored approach based on risk stratification is recommended rather than a “standard, one-size-fits-all” approach. This article will review current risk stratification and preoperative evaluation strategies for patients undergoing elective colorectal surgery. Emphasis will be given to areas in which preoperative optimization strategies may be employed to minimize operative risks. We will review the role and need of preoperative testing in specific patient populations and highlight situations where preoperative evaluation impacts operative timing and planning. Specifically, emphasis will be placed on strategies for mitigation of major adverse cardiac events. The aim is to provide a framework that allows for safe and responsible preoperative assessment.

Keywords

risk stratification - major adverse cardiac events - preoperative assessment

Publikationsverlauf

Artikel online veröffentlicht:
07. April 2025

• References

• 1 Apfelbaum JL, Connis RT, Nickinovich DG. et al.; Committee on Standards and Practice Parameters, American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Practice advisory for preanesthesia evaluation: an updated report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Anesthesiology 2012; 116 (03) 522-538
• 2 Soares Dde S, Brandão RRM, Mourão MRN, Azevedo VL, Figueiredo AV, Trindade ES. Relevance of routine testing in low-risk patients undergoing minor and medium surgical procedures. Braz J Anesthesiol 2013; 63 (02) 197-201
• 3 García-Miguel FJ, Serrano-Aguilar PG, López-Bastida J. Preoperative assessment. Lancet 2003; 362 (9397) 1749-1757
• 4 Colla CH, Morden NE, Sequist TD, Schpero WL, Rosenthal MB. Choosing wisely: prevalence and correlates of low-value health care services in the United States. J Gen Intern Med 2015; 30 (02) 221-228
• 5 American College of Surgeons. ACS NSQIP Risk Calculator. Accessed August 28, 2024 at: https://riskcalculator.facs.org/RiskCalculator/
• 6 Linn BS, Linn MW, Wallen N. Evaluation of results of surgical procedures in the elderly. Ann Surg 1982; 195 (01) 90-96
• 7 Finlayson EV, Birkmeyer JD. Operative mortality with elective surgery in older adults. Eff Clin Pract 2001; 4 (04) 172-177
• 8 Gill TM, Vander Wyk B, Leo-Summers L, Murphy TE, Becher RD. Population-based estimates of 1-year mortality after major surgery among community-living older US adults. JAMA Surg 2022; 157 (12) e225155
• 9 Hall DE, Arya S, Schmid KK. et al. Development and initial validation of the risk analysis index for measuring frailty in surgical populations. JAMA Surg 2017; 152 (02) 175-182
• 10 Varley PR, Borrebach JD, Arya S. et al. Clinical utility of the risk analysis index as a prospective frailty screening tool within a multi-practice, multi-hospital integrated healthcare system. Ann Surg 2021; 274 (06) e1230-e1237
• 11 Reilly DF, McNeely MJ, Doerner D. et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med 1999; 159 (18) 2185-2192
• 12 Fleisher LA, Fleischmann KE, Auerbach AD. et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130 (24) 2215-2245
• 13 Wijeysundera DN, Pearse RM, Shulman MA. et al.; METS Study Investigators. Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study. Lancet 2018; 391 (10140): 2631-2640
• 14 Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009; 250 (01) 166-172
• 15 Smetana GW, Lawrence VA, Cornell JE. American College of Physicians. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 2006; 144 (08) 581-595
• 16 Dindo D, Muller MK, Weber M, Clavien P-A. Obesity in general elective surgery. Lancet 2003; 361 (9374) 2032-2035
• 17 Courcoulas AP, Daigle CR, Arterburn DE. Long term outcomes of metabolic/bariatric surgery in adults. BMJ 2023; 383: e071027
• 18 Griffin SB, Palmer MA, Strodl E, Lai R, Burstow MJ, Ross LJ. Elective surgery in adult patients with excess weight: Can preoperative dietary interventions improve surgical outcomes? A systematic review. Nutrients 2021; 13 (11) 3775
• 19 Griffin SB, Palmer MA, Strodl E. et al. Impact of a dietitian-led very low calorie diet clinic on perioperative risk for patients with obesity awaiting elective, non-bariatric surgery: A retrospective cohort study. Surgery 2024; 175 (02) 463-470
• 20 Grønkjær M, Eliasen M, Skov-Ettrup LS. et al. Preoperative smoking status and postoperative complications: a systematic review and meta-analysis. Ann Surg 2014; 259 (01) 52-71
• 21 Jung KH, Kim SM, Choi MG. et al. Preoperative smoking cessation can reduce postoperative complications in gastric cancer surgery. Gastric Cancer 2015; 18 (04) 683-690
• 22 NICE. Routine preoperative tests for elective surgery: © NICE (2016) Routine preoperative tests for elective surgery. BJU Int 2018; 121 (01) 12-16
• 23 Dobson G, Chow L, Filteau L. et al. Guidelines to the Practice of Anesthesia - Revised Edition 2021. Can J Anaesth 2021; 68 (01) 92-129
• 24 Smetana GW, Macpherson DS. The case against routine preoperative laboratory testing. Med Clin North Am 2003; 87 (01) 7-40
• 25 Goodenough CJ, Liang MK, Nguyen MT. et al. Preoperative glycosylated hemoglobin and postoperative glucose together predict major complications after abdominal surgery. J Am Coll Surg 2015; 221 (04) 854-61.e1
• 26 Lee TH, Marcantonio ER, Mangione CM. et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100 (10) 1043-1049
• 27 Mathew A, Devereaux PJ, O'Hare A. et al. Chronic kidney disease and postoperative mortality: a systematic review and meta-analysis. Kidney Int 2008; 73 (09) 1069-1081
• 28 Shenoy ES, Giuriato MA, Song Z. Prevalence, costs, and consequences of low-value preprocedural urinalyses in the US. JAMA Intern Med 2021; 181 (11) 1533-1535
• 29 The American Society of Anesthesiologists/The Anesthesia Patient Safety Foundation. ASA and APSF Updated Statement on Perioperative Testing for SARS-CoV-2 in the Asymptomatic Patient. 2022 . Accessed August 28, 2024 at: https://www.apsf.org/news-updates/asa-and-apsf-updated-statement-on-perioperative-testing-for-sars-cov-2-in-the-asymptomatic-patient/
• 30 Kristensen SD, Knuuti J. New ESC/ESA guidelines on Non-Cardiac Surgery: cardiovascular assessment and management. Eur Heart J 2014; 35 (35) 2344-2345
• 31 Poirier P, Alpert MA, Fleisher LA. et al.; American Heart Association Obesity Committee of Council on Nutrition, Physical Activity and Metabolism, Council on Cardiopulmonary Perioperative and Critical Care, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovas. Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation 2009; 120 (01) 86-95
• 32 Cinello M, Nucifora G, Bertolissi M. et al. American College of Cardiology/American Heart Association perioperative assessment guidelines for noncardiac surgery reduces cardiologic resource utilization preserving a favourable clinical outcome. J Cardiovasc Med (Hagerstown) 2007; 8 (11) 882-888
• 33 Smetana GW. The conundrum of unnecessary preoperative testing. JAMA Intern Med 2015; 175 (08) 1359-1361
• 34 Lawrence VA, Dhanda R, Hilsenbeck SG, Page CP. Risk of pulmonary complications after elective abdominal surgery. Chest 1996; 110 (03) 744-750
• 35 Smilowitz NR, Gupta N, Ramakrishna H, Guo Y, Berger JS, Bangalore S. Perioperative major adverse cardiovascular and cerebrovascular events associated with noncardiac surgery. JAMA Cardiol 2017; 2 (02) 181-187
• 36 Ganesh R, Kebede E, Mueller M, Gilman E, Mauck KF. Perioperative cardiac risk reduction in noncardiac surgery. Mayo Clin Proc 2021; 96 (08) 2260-2276
• 37 Livhits M, Ko CY, Leonardi MJ, Zingmond DS, Gibbons MM, de Virgilio C. Risk of surgery following recent myocardial infarction. Ann Surg 2011; 253 (05) 857-864
• 38 Livhits M, Gibbons MM, de Virgilio C. et al. Coronary revascularization after myocardial infarction can reduce risks of noncardiac surgery. J Am Coll Surg 2011; 212 (06) 1018-1026
• 39 Sung L-C, Chang C-C, Yeh C-C, Cherng Y-G, Chen T-L, Liao C-C. How long after coronary artery bypass surgery can patients have elective safer non-cardiac surgery?. J Multidiscip Healthc 2024; 17: 743-752
• 40 Kulik A, Ruel M, Jneid H. et al.; American Heart Association Council on Cardiovascular Surgery and Anesthesia. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. Circulation 2015; 131 (10) 927-964
• 41 Kałuza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35 (05) 1288-1294
• 42 Nuttall GA, Brown MJ, Stombaugh JW. et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008; 109 (04) 588-595
• 43 Wilson SH, Fasseas P, Orford JL. et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42 (02) 234-240
• 44 van Kuijk J-P, Flu W-J, Schouten O. et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol 2009; 104 (09) 1229-1234
• 45 Joner M, Finn AV, Farb A. et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48 (01) 193-202
• 46 Amsterdam EA, Wenger NK, Brindis RG. et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 64 (24) e139-e228
• 47 Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med 2006; 119 (12) 1056-1061
• 48 Tsigkas G, Apostolos A, Chlorogiannis D-D. et al. Thirty-days versus longer duration of dual antiplatelet treatment after percutaneous coronary interventions with newer drug-eluting stents: A systematic review and meta-analysis. Life (Basel) 2023; 13 (03) 666